Description
Balchem Corporation: Human Nutrition & Specialty Products Can Drive Future Growth!
Balchem Corporation reported robust financial performance for the third quarter of 2025, setting record figures across key financial metrics. The company achieved consolidated sales of $268 million, which marked an 11.5% increase from the prior year, and delivered record earnings from operations at $55 million, reflecting a 13.7% rise. This resulted in a net income of $40 million, up by 19.1%. On an adjusted basis, their EBITDA also reached a new high at $71 million, revealing an 11% year-over-year gain, accompanied by a strong adjusted net earnings increase of 19.1%, bringing the per share value to $1.35.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
